Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia
Abstract The Genitourinary Pathology Society (GUPS) undertook a critical review of the
recent advances in renal neoplasia, particularly focusing on the newly accumulated …
recent advances in renal neoplasia, particularly focusing on the newly accumulated …
What's new in the WHO 2022 classification of kidney tumours?
Summary The World Health Organization (WHO) 2022 classification of urinary and male
genital tumours (5th edition) has significantly improved our understanding of the …
genital tumours (5th edition) has significantly improved our understanding of the …
[HTML][HTML] New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia
Abstract The Genitourinary Pathology Society (GUPS) reviewed recent advances in renal
neoplasia, particularly post-2016 World Health Organization (WHO) classification, to provide …
neoplasia, particularly post-2016 World Health Organization (WHO) classification, to provide …
The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer
H Izumi, S Matsumoto, J Liu, K Tanaka, S Mori… - Nature, 2021 - nature.com
Lung cancer is one of the most aggressive tumour types. Targeted therapies stratified by
oncogenic drivers have substantially improved therapeutic outcomes in patients with non …
oncogenic drivers have substantially improved therapeutic outcomes in patients with non …
[HTML][HTML] Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization
The discovery of actionable kinase gene rearrangements has revolutionized the therapeutic
landscape of thyroid carcinomas. Unsolved challenges include histopathologic recognition …
landscape of thyroid carcinomas. Unsolved challenges include histopathologic recognition …
Translocation carcinomas of the kidney
The MiT subfamily of transcription factors includes TFE3, TFEB, TFEC, and MITF. Gene
fusions involving two of these transcription factors have been well‐characterized in renal cell …
fusions involving two of these transcription factors have been well‐characterized in renal cell …
French AFU Cancer committee guidelines-update 2022-2024: management of kidney cancer
Aim To update the recommendations for the management of kidney cancers. Methods A
systematic review of the literature was conducted from 2015 to 2022. The most relevant …
systematic review of the literature was conducted from 2015 to 2022. The most relevant …
Towards a new WHO classification of renal cell tumor: What the clinician needs to know—A narrative review
In 1952, renal cell carcinomas had been divided into 2 categories—clear cell or granular cell—
depending upon their cytoplasmic staining characteristics. In the following years, the …
depending upon their cytoplasmic staining characteristics. In the following years, the …
[HTML][HTML] Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 …
Most succinate dehydrogenase (SDH)-deficient renal cell carcinomas (RCCs) demonstrate
stereotypical morphology characterized by bland eosinophilic cells with frequent …
stereotypical morphology characterized by bland eosinophilic cells with frequent …
Systemic therapies for the management of non–clear cell renal cell carcinoma: what works, what Doesn't, and what the future holds
Non–clear cell renal cell carcinoma (nccRCC) is a broad term that refers to a diverse group
of tumors, each with its own distinct biologic and therapeutic profile. The management of …
of tumors, each with its own distinct biologic and therapeutic profile. The management of …